跳至主要内容
临床试验/NCT02862301
NCT02862301Unknown不适用

Epigenetic Evaluation of HAT/HDAC Activity in Peripheral Blood Mononuclear Cells From Patients With Clinically Isolated Syndrome and Analysis of the Relationship With the Pathophysiology and Disease Activity

Centre Hospitalier Universitaire de Besancon1 个研究点 分布在 1 个国家目标入组 55 人开始时间: 2016年4月最近更新:
适应症

试验速览

阶段
不适用
入组人数
55
试验地点
1
主要终点
HDAC/ HAT enzymatic activity (ratio)

研究概览

简要总结

The aim of the study is to compare the enzymatic activity of HATs and HDACs in peripheral blood mononuclear cell (PBMC) of patients with a clinically isolated syndrome (CIS group) and healthy controls (control group).

详细描述

Multiple sclerosis (MS) is an autoimmune inflammatory demyelinating disease of the central nervous system (CNS). Clinically isolated syndrome (CIS) is often a sign of multiple sclerosis and the term refers to the first episode of neurologic symptoms experienced by a patient. Possible presentations of CIS include optic neuritis, a brain stem and/or cerebellar syndrome, a spinal cord syndrome, or occasionally cerebral hemispheric dysfunction. An accurate diagnosis at this time is important because people with a high risk of developing MS are encouraged to begin treatment in order to delay or prevent a second neurologic episode and, therefore, the onset of MS.

The innate and adaptative immune systems play an important role in pathophysiology of MS, acting in interaction with environmental, genetic, and epigenetic factors.

Epigenetic modifications, such as DNA methylation and histone modification, alter DNA accessibility and chromatin structure, thereby regulating patterns of gene expression. These processes are crucial to normal development and differentiation of distinct cell lineages in the adult organism. Histone acetylation, through the family of histone acetyl transferase (HAT), is most consistently associated with promoting transcription. Deacetylation of histones correlates with CpG methylation and the inactive state of chromatin. There are 4 classes of histone deacetylase enzymes (HDACs), with members capable of deacetylation of histones and/or other protein targets. Acetylation homeostasis is a key regulator of both immune cell activation. Of note, potent histone deacetylase inhibitors (HDACi) endowed with antiinflammatory and neuroprotective properties have been identified. Efficacy of HDACi in experimental models of MS has been reported consistently. This study could provide information on the mechanisms involved.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Clinically isolated syndrome within the last 6 weeks (CIS group)
  • Healthy volunteer, free of any inflammatory disease (control group)
  • Patient able to understand the reason of the study
  • Signed informed consent

排除标准

  • Pregnancy
  • Systemic corticosteroid therapy (>1mg/kg)
  • Immunosuppressive/immunomodulatory therapy (prior or ongoing) (CIS group)
  • Patient with ongoing infection (Control group)

结局指标

主要结局

HDAC/ HAT enzymatic activity (ratio)

时间窗: day of inclusion

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Epigenetic Evaluation of HAT/HDAC Activity in PBMC... | 临床试验